Journal Article

Resolving colistin resistance and heteroresistance in Enterobacter species

Walker, Sarah V., Falgenhauer, Linda, Gastmeier, Petra, Kola, Axel, Falgenhauer, Jane, Tacconelli, Evelina, Peter, Silke, Kumbhar, Bajarang Vasant, Zweigner, Janine, Seifert, Harald, Chakraborty, Trinad, Gisch, Nicolas, Vehreschild, Maria J. G. T., Behnke, Michael, Doijad, Swapnil Prakash, Kramme, Evelyn, Rohde, Anna M., Eisenbeis, Simone, Mischnik, Alexander, Rupp, Jan, Buhl, Michael, Frantz, Renate, Käding, Nadja, Häcker, Georg Alexander, Gölz, Hanna, Schwudke, Dominik, Imirzalioglu, Can, Kern, Winfried V.

2023

Overview

Species within the Enterobacter cloacae complex (ECC) include globally important nosocomial pathogens. A three-year study of ECC in Germany identified Enterobacter xiangfangensis as the most common species (65.5%) detected, a result replicated by examining a global pool of 3246 isolates. Antibiotic resistance profiling revealed widespread resistance and heteroresistance to the antibiotic colistin and detected the mobile colistin resistance ( mcr )−9 gene in 19.2% of all isolates. We show that resistance and heteroresistance properties depend on the chromosomal arnBCADTEF gene cassette whose products catalyze transfer of L-Ara4N to lipid A. Using comparative genomics, mutational analysis, and quantitative lipid A profiling we demonstrate that intrinsic lipid A modification levels are genospecies-dependent and governed by allelic variations in phoPQ and mgrB , that encode a two-component sensor-activator system and specific inhibitor peptide. By generating phoPQ chimeras and combining them with mgrB alleles, we show that interactions at the pH-sensing interface of the sensory histidine kinase phoQ dictate arnBCADTEF expression levels. To minimize therapeutic failures, we developed an assay that accurately detects colistin resistance levels for any ECC isolate. Taxonomical complexity has muddled the classification of clinically relevant Enterobacter species. Authors carry out a genome-based study on clinical isolates to investigate colistin resistance and heteroresistance in Enterobacter .

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 14/34 / 14/63 / 140/58 / 38/22 / 38/23 / 38/43 / 38/44 / 38/88 / 38/90 / 631/326/107 / 631/326/22/1434 / 631/326/325/2482 / 631/326/41/2530 / Anti-Bacterial Agents - pharmacology / Anti-Bacterial Agents - therapeutic use / Antibiotic resistance / Antibiotics / Bacterial Proteins - metabolism / Chimeras / Clinical isolates / Colistin / Colistin - pharmacology / Colistin - therapeutic use / Complexity / Drug Resistance, Bacterial - genetics / Enterobacter / Enterobacter - genetics / Enterobacter cloacae / Histidine / Histidine kinase / Humanities and Social Sciences / Kinases / Lipid A / Lipid A - chemistry / Lipid A - pharmacology / Lipids / Microbial Sensitivity Tests / multidisciplinary / Nosocomial infection / Science / Science (multidisciplinary)